Cargando…

Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection

BACKGROUND AND AIMS: Hepatitis D virus (HDV) infection causes the most severe form of chronic viral hepatitis. However, it is still unclear to what extent the underlying cirrhosis may contribute to disease progression. The aim of this study was to compare the long-term outcome of HDV infection with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wranke, Anika, Heidrich, Benjamin, Deterding, Katja, Hupa-Breier, Katharina Luise, Kirschner, Janina, Bremer, Birgit, Cornberg, Markus, Wedemeyer, Heiner
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661878/ https://www.ncbi.nlm.nih.gov/pubmed/37789170 http://dx.doi.org/10.1007/s12072-023-10575-0

Ejemplares similares

HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis Delta
por: Sandmann, Lisa, et al.
Publicado: (2021)

Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients
por: Owusu Sekyere, Solomon, et al.
Publicado: (2021)

Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta
por: Wranke, Anika, et al.
Publicado: (2014)

Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity
por: Strunz, Benedikt, et al.
Publicado: (2018)

Development and evaluation of a baseline-event-anticipation score for hepatitis delta
por: Calle Serrano, B, et al.
Publicado: (2014)

Soluble immune markers in the different phases of chronic hepatitis B virus infection
por: Wiegand, Steffen B., et al.
Publicado: (2019)

Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy
por: Ravens, Sarina, et al.
Publicado: (2018)

Prevalence and risk factors for patient-reported joint pain among patients with HIV/Hepatitis C coinfection, Hepatitis C monoinfection, and HIV monoinfection
por: Ogdie, Alexis, et al.
Publicado: (2015)

Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting
por: Maasoumy, Benjamin, et al.
Publicado: (2013)

Hepatocellular Carcinoma in Hepatitis D: Does it Differ from Hepatitis B Monoinfection?
por: Abbas, Zaigham, et al.
Publicado: (2012)

Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection
por: Aliabadi, Elmira, et al.
Publicado: (2022)

Dulaglutide Alone and in Combination with Empagliflozin Attenuate Inflammatory Pathways and Microbiome Dysbiosis in a Non-Diabetic Mouse Model of NASH
por: Hupa-Breier, Katharina Luise, et al.
Publicado: (2021)

Long-Lasting Imprint in the Soluble Inflammatory Milieu Despite Early Treatment of Acute Symptomatic Hepatitis C
por: Khera, Tanvi, et al.
Publicado: (2021)

Chronic hepatitis B virus monoinfection at a university hospital in Zambia
por: Vinikoor, Michael J, et al.
Publicado: (2018)

Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: The HepNet acute HCV-V study
por: Maasoumy, Benjamin, et al.
Publicado: (2022)

PEG-IFN Alpha but Not Ribavirin Alters NK Cell Phenotype and Function in Patients with Chronic Hepatitis C
por: Markova, Antoaneta A., et al.
Publicado: (2014)

Treatment outcomes with telaprevir-based therapy for HIV/hepatitis C coinfected patients are comparable with hepatitis C monoinfected patients
por: O’Neil, Conar R, et al.
Publicado: (2015)

Comparison of Patients Monoinfected with Hepatitis C Virus and Coinfected with Hepatitis B/C in the Amazon Region of Brazil
por: Sampaio, Regiane M. A., et al.
Publicado: (2022)

In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome
por: Todt, Daniel, et al.
Publicado: (2016)

Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping Review
por: Sperle, Ida, et al.
Publicado: (2020)

Nephrogenic hypophosphatemic osteomalacia during adefovir monotherapy for chronic hepatitis B monoinfection
por: Xu, Yaowen, et al.
Publicado: (2013)

Commutability and concordance of four hepatitis B virus DNA assays in an international multicenter study
por: Maasoumy, Benjamin, et al.
Publicado: (2017)

645 Structural Bone Deficits in HIV/HCV, HCV-Monoinfected, and HIV-Monoinfected Women
por: Lo Re, Vincent, et al.
Publicado: (2014)

Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008–2019
por: Maisa, Anna, et al.
Publicado: (2021)

Corrigendum: Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008–2019
por: Maisa, Anna, et al.
Publicado: (2022)

Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C‐Registry
por: Tacke, Frank, et al.
Publicado: (2022)

Treatment of Naïve Patients with Chronic Hepatitis C Genotypes 2 and 3 with Pegylated Interferon Alpha and Ribavirin in a Real World Setting: Relevance for the New Era of DAA
por: Heidrich, Benjamin, et al.
Publicado: (2014)

Daily Low-Volume Paracentesis and Clinical Complications in Patients With Refractory Ascites
por: Tergast, Tammo L., et al.
Publicado: (2023)

Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting
por: Wiegand, Steffen B., et al.
Publicado: (2015)

Enhanced monitoring and detection of recent genotype 3 hepatitis E virus infection through urine antigen testing
por: Stahl, Yannick, et al.
Publicado: (2023)

Effects of renin–angiotensin inhibitors on renal function and the clinical course in patients with decompensated cirrhosis
por: Tergast, Tammo L., et al.
Publicado: (2023)

Ledipasvir and Sofosbuvir for Acute Hepatitis C Virus Monoinfection Associated with a High Risk of Acute Liver Failure
por: Hatanaka, Takeshi, et al.
Publicado: (2019)

Impfstoffe gegen Hepatitis E: Wo stehen wir?
por: Behrendt, Patrick, et al.
Publicado: (2022)

Type I Interferon Elevates Co-Regulatory Receptor Expression on CMV- and EBV-Specific CD8 T Cells in Chronic Hepatitis C
por: Owusu Sekyere, Solomon, et al.
Publicado: (2015)

Cytomegalovirus-Driven Adaptive-Like Natural Killer Cell Expansions Are Unaffected by Concurrent Chronic Hepatitis Virus Infections
por: Malone, David F. G., et al.
Publicado: (2017)

Hepatitis E In Transplant Recipients: Why Is This Not A Problem In Japan?
por: Pischke, Sven, et al.
Publicado: (2015)

The New Era of Interferon-Free Treatment of Chronic Hepatitis C
por: Solbach, Philipp, et al.
Publicado: (2015)

Experimental Drugs for the Treatment of Hepatitis D
por: Sandmann, Lisa, et al.
Publicado: (2021)

A case report of sofosbuvir and daclatasvirto treat a patient with acute hepatitis C virus genotype 2 monoinfection
por: Li, Chen, et al.
Publicado: (2018)

High Kynurenine:Tryptophan Ratio Is Associated With Liver Fibrosis in HIV-Monoinfected and HIV/Hepatitis C Virus–Coinfected Women
por: Kardashian, Ani, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dv83kk0ecoqmq4l08tpfv5gro1